Fujian Aonong Biological Technology Group Incorporation 대차 대조표 상태
재무 상태 기준 확인 2/6
Fujian Aonong Biological Technology Group Incorporation has a total shareholder equity of CN¥-1.4B and total debt of CN¥6.8B, which brings its debt-to-equity ratio to -469.7%. Its total assets and total liabilities are CN¥11.8B and CN¥13.3B respectively.
주요 정보
-469.7%
부채 비율
CN¥6.81b
부채
| 이자 보상 비율 | n/a |
| 현금 | CN¥382.19m |
| 주식 | -CN¥1.45b |
| 총 부채 | CN¥13.26b |
| 총 자산 | CN¥11.81b |
재무 상태 분석
단기부채: 603363 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
장기 부채: 603363 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
부채 대 자본 내역 및 분석
부채 수준: 603363 has negative shareholder equity, which is a more serious situation than a high debt level.
부채 감소: 603363's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: Whilst unprofitable 603363 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
예측 현금 활주로: 603363 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 15.6% per year.